Ticker: CRL

Company: CHARLES RIVER LABORATORIES HOLDINGS INC

Person: Mark J Enyedy, director

Transaction date: May 8, 2026

Reporting date: May 11, 2026

Average share price: 177.62

Bought 1438.0 shares for 255417.56